Evidence map›Paper›PMID 37798075›Full record

ArticleThe British journal of ophthalmology2024

Automated expert-level scleral spur detection and quantitative biometric analysis on the ANTERION anterior segment OCT system.

Kyle Bolo, Galo Apolo Aroca, Anmol A Pardeshi, Michael Chiang, Bruce Burkemper, Xiaobin Xie, Alex S Huang, Martin Simonovsky, Benjamin Y Xu

Abstract readValidation Study
In one paragraph

Article in The British journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kyle BoloRoski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.ORCID 0000-0001-7885-192X
Galo Apolo ArocaRoski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.ORCID 0000-0001-5751-6102
Anmol A PardeshiRoski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Michael ChiangRoski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Bruce BurkemperRoski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Xiaobin XieEye Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Alex S HuangHamilton Glaucoma Center and Shiley Eye Institute, Department of Ophthalmology, University of California, San Diego, California, USA.
Martin SimonovskyHeidelberg Engineering, Heidelberg, Germany.
Benjamin Y XuRoski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, Los Angeles, California, USA Benjamin.Xu@med.usc.edu.ORCID 0000-0003-1573-988X

Funding

Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human EyeR01EY030501 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Alex Huang, Hao F Zhang · 2020 to 2026
$3.5M
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure DiseaseK23EY029763 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI XU, BENJAMIN Y. · 2019 to 2023
$1.1M
NEI NIH HHS K23 EY029763NEI NIH HHS R01 EY030501
6 · The paper itself

Abstract

aimTo perform an independent validation of deep learning (DL) algorithms for automated scleral spur detection and measurement of scleral spur-based biometric parameters in anterior segment optical coherence tomography (AS-OCT) images.

methodsPatients receiving routine eye care underwent AS-OCT imaging using the ANTERION OCT system (Heidelberg Engineering, Heidelberg, Germany). Scleral spur locations were marked by three human graders (reference, expert and novice) and predicted using DL algorithms developed by Heidelberg Engineering that prioritise a false positive rate <4% (FPR4) or true positive rate >95% (TPR95). Performance of human graders and DL algorithms were evaluated based on agreement of scleral spur locations and biometric measurements with the reference grader.

results1308 AS-OCT images were obtained from 117 participants. Median differences in scleral spur locations from reference locations were significantly smaller (p<0.001) for the FPR4 (52.6±48.6 µm) and TPR95 (55.5±50.6 µm) algorithms compared with the expert (61.1±65.7 µm) and novice (79.4±74.9 µm) graders. Intergrader reproducibility of biometric measurements was excellent overall for all four (intraclass correlation coefficient range 0.918-0.997). Intergrader reproducibility of the expert grader (0.567-0.965) and DL algorithms (0.746-0.979) exceeded that of the novice grader (0.146-0.929) for images with narrow angles defined by OCT measurement of angle opening distance 500 µm anterior to the scleral spur (AOD500)<150 µm.

conclusionsDL algorithms on the ANTERION approximate expert-level measurement of scleral spur-based biometric parameters in an independent patient population. These algorithms could enhance clinical utility of AS-OCT imaging, especially for evaluating patients with angle closure and performing intraocular lens calculations.

Indexed as

AlgorithmsBiometryScleraTomography, Optical CoherenceAgedAged, 80 and overAnterior Eye SegmentDeep LearningFemaleGlaucoma, Angle-ClosureHumansIntraocular PressureMaleMiddle AgedReproducibility of Resultsangleanterior chamberdiagnostic tests/investigationglaucoma

Identifiers

PMID37798075
PMCPMC10995103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.